Skip to main content

and
  1. Article

    Open Access

    Final analysis of a phase II trial of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma without transplant

    We evaluated the efficacy and safety of 24 cycles of Dara in combination with carfilzomib (K), lenalidomide (R), and dexamethasone (d) without autologous stem cell transplant (ASCT) in newly diagnosed multiple...

    Benjamin A. Derman, Jennifer Cooperrider, Jacalyn Rosenblatt in Blood Cancer Journal (2024)

  2. Article

    Open Access

    Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment

    Human papillomavirus (HPV)-associated oropharyngeal cancer (OPC) has a favorable prognosis which has led to efforts to de-intensify treatment. Response-adaptive de-escalated treatment is promising, however imp...

    Ari J. Rosenberg, Evgeny Izumchenko, Alexander Pearson, Zhen Gooi in BMC Cancer (2022)